About the Consortium
About the Consortium
The Viral Hemorrhagic Fever Consortium is a partnership of research institutes whose mission is to promote global health and safety by creating new products to diagnose, treat and significantly reduce the incidence and mortality rate of viral hemorrhagic fevers. Learn more.
Updates & Blogs
Updates & Blogs
-
Sunday, February 12, 2012 - 11:29
-
Saturday, February 11, 2012 - 22:11
-
Tuesday, December 6, 2011 - 14:06
-
Tuesday, November 15, 2011 - 11:45
Featured Story
Featured Story
Harvard researchers describe potential genetic resistance to LassaRapidly evolving viruses and other pathogens can have an immense impact on human evolution as natural selection acts to increase the prevalence of genes providing resistance to disease. In their new paper, Andersen et al, provide evidence for two genes - IL21 and LARGE - as being targets of natural selection caused by Lassa virus. Read more |
![]() |








